Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder

NCT00113295 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00113295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00113295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2004
Completion date
November 30, 2007
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorder